Get startedLog in
    Picture of Stayble Therapeutics AB logo

    STABL — Stayble Therapeutics AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Stayble Therapeutics Q3 EBIT Loss SEK 6.1 Million

    Picture of Stayble Therapeutics AB logoStayble Therapeutics AB
    15/11/2022 07:12
    Nov 15 (Reuters) - Stayble Therapeutics AB  STABL.ST :
    * Q3 EBIT LOSS SEK 6.1 MILLION VERSUS LOSS SEK 3.0 MILLION
YEAR
AGO
    * Q3 NET LOSS SEK  5.9 MILLION VERSUS LOSS SEK 3.1 MILLION
YEAR
AGO

Source text for Eikon:  ID:nWkr2j0FY2 
Further company coverage:  STABL.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Stayble Therapeutics AB

    See all news